Cepheid and the Knight Cancer Institute collaborate to develop breast, prostate cancer tests
February 19, 2013
The Knight Cancer Institute at Oregon Health & Science University (OHSU) and Cepheid (Nasdaq: CPHD) today announced a collaboration to develop a menu of advanced molecular diagnostics to be performed on the GeneXpert system. The collaboration will ...
